Epiq Systems, Inc. EPIQ
Epiq's board has insulated management through chronic guidance misses, a failed Iris acquisition and governance entrenchment; electing Villere's alternate slate is the unique opportunity to unlock value.
Thesis
Epiq Systems has delivered persistent long-term share price underperformance — trailing the Russell 3000 by 58.9% and proxy peers by 62.6% over ten years — while management missed revenue guidance in 5 of 8 years and EBITDA and EPS guidance in 7 of 8 years. The recently acquired $134mm Iris Data Services is already running at only 83% of budgeted revenue, and unallocated corporate EBITDA and SG&A have ballooned even as EPS declined 10% from 2012 to 2015. Despite this, CEO compensation rose from $3.0m to $3.9m, ISS and Glass Lewis opposed pay plans in 2013 and 2014, and the Board rejected P2 Capital's $20 buyout proposal — with shares now ~28% below that bid. Marcato, owning 4.8%, argues shareholders must elect Villere & Co.'s alternate director slate at the 2016 annual meeting to restore accountability and maximize value.
SCQA
Epiq Systems is a legal and bankruptcy services technology provider whose 4.8%-owned stake Marcato holds, operating under a long-tenured management team and an incumbent board that has controlled strategy and compensation for years.
Management has missed EBITDA and EPS guidance in 7 of 8 years, the $134mm Iris acquisition is already 17% short of plan, SG&A has exploded, and the board has erected bylaw, poison-pill and standstill obstacles to shareholder action.
Shareholders should elect Villere & Co.'s competing slate of highly-qualified directors at Epiq's 2016 annual meeting — now court-approved — to drive management accountability, reset capital allocation discipline and chart a new strategic course.
Closing the credibility discount and re-engaging strategic alternatives such as P2 Capital's rejected $20 proposal would recover the ~28% gap between the current ~$14 price and the prior bid, plus longer-term peer-catch-up upside.
The three reasons
- 1
Epiq has underperformed Russell 3000 by 58.9% and peers by 62.6% over 10 years
- 2
Management missed EBITDA and EPS guidance in 7 of 8 years while CEO pay rose to $3.9m
- 3
Board rejected P2's $20 bid; stock now trades ~28% below that offer
Primary demands
- Replace incumbent directors with Villere & Co.'s alternate slate at the 2016 annual meeting
- Drive management accountability for repeated guidance misses and poor capital allocation
- Run a credible strategic review; re-engage with P2 Capital's $20/share proposal rejected by the Board
KPIs cited
Pattern membership
Where this document fits across the library's 12 rhetorical / structural patterns.
Notable slides (6)
Notes
Short 13-page proxy-fight deck. Marcato backs Villere & Co.'s alternate director slate following a Missouri court ruling permitting Villere's nominations. Quotes William Blair sell-side research and cites ISS/Glass Lewis opposition as third-party credibility props. No explicit target price; implied upside anchored on P2 Capital's rejected $20 bid. No named primary author — firm-authored.